Effect of Gabexate Mesylate (FOY), a Drug for Serine Proteinase-Mediated Diseases, on the Nitric Oxide Pathway
- 19 May 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 246 (2) , 453-456
- https://doi.org/10.1006/bbrc.1998.8642
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Biosynthesis and action of nitric oxide in mammalian cellsTrends in Biochemical Sciences, 1997
- Competitive Inhibition of Swine Kidney Copper Amine Oxidase by Drugs: Amiloride, Clonidine, and Gabexate MesylateBiochemical and Biophysical Research Communications, 1997
- Nitric Oxide Down-regulates Hepatocyte–Inducible Nitric Oxide Synthase Gene ExpressionArchives of Surgery, 1997
- Neuronal (type I) nitric oxide synthase regulates nuclear factorκB activity and immunologic (type II) nitric oxide synthase expressionProceedings of the National Academy of Sciences, 1997
- Competitive Inhibition of Nitric Oxide Synthase byp-Aminobenzamidine, a Serine Proteinase InhibitorBiochemical and Biophysical Research Communications, 1997
- Induction of Nitric Oxide Synthase mRNA ExpressionJournal of Biological Chemistry, 1995
- Inhibition of inducible nitric oxide synthase mRNA expression by basic fibroblast growth factor in human microglial cellsNeuroscience Letters, 1995
- Nitric Oxide Limits Transcriptional Induction of Nitric Oxide Synthase in CNS Glial CellsBiochemical and Biophysical Research Communications, 1994
- Spectrophotometric detection of nitrogen oxides using azo dyesNeuroprotocols, 1992
- Gabexate Mesylate Inhibition of Serine Proteases: Thermodynamic and Computer-Graphics AnalysisJournal of Pharmaceutical Sciences, 1986